UBS Group
ALVO icon

UBS Group’s Alvotech ALVO Stock Holding History

UBS Group’s Portfolio ALVO Stock Details ALVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$935K Sell
253,482
-68,675
-21% -$245K ﹤0.01% 5791
2026
Q1 		$1.1M Buy
322,157
+186,097
+137% +$818K ﹤0.01% 5476
2025
Q4 		$698K Buy
136,060
+109,322
+409% +$691K ﹤0.01% 5860
2025
Q3 		$219K Sell
26,738
-15,865
-37% -$135K ﹤0.01% 6622
2025
Q2 		$389K Sell
42,603
-4,980
-10% -$46.8K ﹤0.01% 6220
2025
Q1 		$460K Sell
47,583
-12,451
-21% -$151K ﹤0.01% 5914
2024
Q4 		$794K Buy
60,034
+59,066
+6,102% +$727K ﹤0.01% 5486
2024
Q3 		$11.5K Buy
968
+966
+48,300% +$11.2K ﹤0.01% 7675
2024
Q2 		$24 Hold
2
– – ﹤0.01% 9294
2024
Q1 		$24 Buy
+2
New +$29 ﹤0.01% 9013
2023
Q4 		– Sell
-78
Closed -$711 – 9259
2023
Q3 		$711 Buy
+78
New +$723 ﹤0.01% 8317
2023
Q2 		– Sell
-2,283
Closed -$29.5K – 8853
2023
Q1 		$29.5K Sell
2,283
-299
-12% -$3.83K ﹤0.01% 6815
2022
Q4 		$25.8K Sell
2,582
-8,157
-76% -$57K ﹤0.01% 7392
2022
Q3 		$73K Sell
10,739
-2,907
-21% -$22.4K ﹤0.01% 5991
2022
Q2 		$112K Buy
+13,646
New +$127K ﹤0.01% 5335

Other funds holding ALVO

RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $5.53B AUM 25.79% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LC
Littlejohn & Co Greenwich, Connecticut $78.6M AUM 1.93% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

UBS Group's ALVO Position: Q2 2026 in Review

UBS Group reduced its Alvotech (ALVO) stake by 21% in Q2 2026, selling an estimated $245K and leaving 253,482 shares worth $935K. The position accounts for ﹤0.01% of the portfolio, ranked #5791.

UBS Group first reported a position in ALVO in Q2 2022 and has held it in 15 quarters since. The position peaked at $1.1M in Q1 2026. 72 funds tracked by Wall St. Rank hold ALVO as of Q2 2026.

  • UBS Group held 253,482 shares of Alvotech worth $935K as of Q2 2026.
  • UBS Group sold 68,675 Alvotech shares in Q2 2026, an estimated $245K.
  • Alvotech made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #5791 holding.
  • UBS Group first reported a position in Alvotech in Q2 2022 and has held it in 15 quarters since.
  • UBS Group's Alvotech position peaked at $1.1M in Q1 2026.
  • 72 funds tracked by Wall St. Rank held Alvotech as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.